GSK’s COVID-19 Antibody Treatment Approved in Japan

GSK’s COVID-19 Antibody Treatment Approved in Japan

GSK’s (GlaxoSmithKline) and Vir Biotechnology’s antibody treatment for COVID-19, Sotrovimab has been approved in Japan, Health Minister Norihisa Tamura announced this week. Aiming to treat mild to moderate coronavirus cases, GSK’s antibody treatment...
Pfizer-BioNTech Booster Gains FDA Limited Authorization

Pfizer-BioNTech Booster Gains FDA Limited Authorization

Pfizer-BioNTech has been granted FDA (Food and Drug Administration) authorization for its booster shot for people aged 65 and older, as well as individuals at high risk for severe disease and those working in patient-facing healthcare, six months are their second...